Novelion Therapeutics Inc. announced that the implementation of the Company's voluntary liquidation (the Liquidation) commenced at 5:00 p.m. Pacific Time, January 16, 2020 (the Effective Date). Concurrent with the Liquidator's appointment: Michael Price, previously Executive Vice President, Chief Financial Officer and sole executive officer and employee of the Company, resigned his positions, and Michael Price, Suzanne Bruhn, and Stephen Sabba resigned as directors of the Company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -4.49% | -0.54% |
2022 | Novelion Therapeutics Inc. Announces Final Cash Distribution, Payable on or About March 31, 2022 | CI |
2020 | Novelion Therapeutics Inc. Announces Management Changes | CI |
- Stock Market
- Equities
- NVLNF Stock
- News Novelion Therapeutics Inc.
- Novelion Therapeutics Inc. Announces Management Changes